Repros Therapeutics Inc Share Price

Stocks

27/18/27	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
16/17/16	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
13/17/13	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
12/17/12	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
12/17/12	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

02/15/02	Apple : Les valeurs à suivre sur les marchés américains
02/15/02	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	+1.70%	+7.41%	+3.12%	+8.46%	4.99TCr
REVOLUTION MEDICINES, INC.	+0.92%	+3.93%	+399.71%	+605.33%	4.02TCr
IQVIA HOLDINGS INC.	+1.89%	+8.32%	+26.06%	-6.35%	3.46TCr
BEONE MEDICINES AG	+2.38%	+6.35%	+21.25%	+64.58%	3.31TCr
CELLTRION, INC.	+3.96%	+10.67%	+11.89%	+38.86%	2.75TCr
ASCENDIS PHARMA A/S	+2.51%	+5.27%	-	-	1.7TCr
MEDPACE HOLDINGS, INC.	+2.58%	+5.79%	+73.44%	+133.27%	1.59TCr
EUROFINS SCIENTIFIC SE	+0.32%	+0.58%	+13.67%	+19.09%	1.39TCr
IONIS PHARMACEUTICALS, INC.	+3.30%	+0.76%	+90.23%	+99.12%	1.35TCr
Average	+1.96%	+5.82%	+79.92%	+120.30%	2.73TCr
Weighted average by Cap.	+2.07%	+6.53%	+90.75%	+137.74%

Employees

Sector